News
Myocarditis by CMR may be rare after COVID-19 in elite athletes
Some supposed ‘myocarditis’ detected by MRI after COVID-19 in university varsity competitors might be normal heart muscle – normal for athletes,...
News
Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes
Together, four “easily measured” biomarkers predicted 5-year heart failure risk in patients with diabetes or prediabetes, potentially identifying...
News
Calcium burden drives CV risk whether coronary disease is obstructive or not
That future cardiovascular risk tracks closely with plaque burden, but not so much with whether the coronary disease is obstructive, may never...
News
SAMSON pins most muscle pain experienced with statins on the nocebo effect
Some patients really do get side effects, such as muscle pain, from statins, but the trial suggests that “90% of this symptomatic burden is...
News
Omega-3 caps, vitamin D both fail for atrial fib primary prevention: VITAL-Rhythm
Neither supplement, here used as drugs, made a difference in risk for incident atrial fibrillation in the 5-year trial. And a secondary...
News
Virtual AHA 2020 may influence template for postpandemic scientific sessions
The American Heart Association has assembled a virtual meeting that retains many familiar features and formats, and even includes an address from...
News
PCI success vs. meds only in diabetes may depend on LDL-C control
PCI and LDL-lowering therapy work as a team to cut clinical risk in patients with diabetes and stable coronary disease, but succeed only if LDL-C...
News
The socioeconomic revolving door of 30-day heart failure readmissions
Racial disparities in 30-day HF readmissions stem partly from variation in economic status of residential neighborhoods, regardless of hospital...
News
‘Cautious’ DOAC underdosing in AFib may push mortality higher
Risk-averse clinicians might be doing more harm than good by prescribing direct oral anticoagulants at lower-than-recommended dosages in hope of...
News
Minidose edoxaban may safely cut AFib stroke risk in the frail, very elderly
Those who took the factor Xa inhibitor edoxaban (Savaysa) at the off-label dosage of 15 mg once daily showed a two-thirds drop in risk for stroke...
News
EXPLORER trial hints at potential new drug option in obstructive hypertrophic cardiomyopathy
Mavacamten, which seemed to improve function and alleviate symptoms in the short trial, is the first potential drug for the disorder that...
News
Vast underdiagnosis of monogenic CV disease seen in cath referrals
Most such patients with a heart disease–linked gene variant and who showed clinical signs of the disease did not receive a diagnosis, in a study...
News
All NSAIDs raise post-MI risk but some are safer than others: Next chapter
A new cohort analysis extends NSAID cautions in high-CV-risk patients to a Korean population. Some question whether the steep climbs in risk seen...
News
Heart damage even after COVID-19 ‘recovery’ evokes specter of later heart failure
Recovery from acute COVID-19 isn’t necessarily the end of it, clearly. Two reports aim to clarify how SARS-CoV-2 can directly invade the heart and...
News
SCD-HeFT 10-year results: Primary-prevention ICD insights in nonischemic heart failure
The trial’s most recent results add to ongoing controversy – fueled by DANISH and other studies – about whether primary-prevention ICDs prolong...